UK markets open in 2 hours 25 minutes
  • NIKKEI 225

    27,379.45
    +16.70 (+0.06%)
     
  • HANG SENG

    22,582.25
    +15.47 (+0.07%)
     
  • CRUDE OIL

    81.37
    +0.36 (+0.44%)
     
  • GOLD FUTURES

    1,923.80
    -6.20 (-0.32%)
     
  • DOW

    33,949.41
    +205.57 (+0.61%)
     
  • BTC-GBP

    18,451.50
    -358.84 (-1.91%)
     
  • CMC Crypto 200

    517.35
    -9.84 (-1.87%)
     
  • ^IXIC

    11,512.41
    +199.06 (+1.76%)
     
  • ^FTAS

    4,253.35
    +11.50 (+0.27%)
     

The Global Chronic Obstructive Pulmonary Disease Drugs Market is forecast to grow by $6654.49 mn during 2022-2027, accelerating at a CAGR of 6.09% during the forecast period

ReportLinker
ReportLinker

Global Chronic Obstructive Pulmonary Disease Drugs Market 2023-2027 The analyst has been monitoring the chronic obstructive pulmonary disease drugs market and is forecast to grow by $6654.

New York, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Chronic Obstructive Pulmonary Disease Drugs Market 2023-2027" - https://www.reportlinker.com/p04016579/?utm_source=GNW
49 mn during 2022-2027, accelerating at a CAGR of 6.09% during the forecast period. Our report on the chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of COPD, strong pipeline and new drug approvals, and growing demand for fixed-dose combinations.

The chronic obstructive pulmonary disease drugs market is segmented as below:
By Product
• Combination therapy
• Monotherapy

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years. Also, advances in drug delivery devices and the growing use of e-cigarettes and other products for people to quit smoking will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the chronic obstructive pulmonary disease drugs market covers the following areas:
• Chronic obstructive pulmonary disease drugs market sizing
• Chronic obstructive pulmonary disease drugs market forecast
• Chronic obstructive pulmonary disease drugs market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic obstructive pulmonary disease drugs market vendors that include AstraZeneca Plc, Exela Pharma Sciences LLC, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Mundipharma International Ltd., Novartis AG, Theravance Biopharma Inc., Vertex Pharmaceuticals Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Ltd., Philip Morris International Inc., Shionogi and Co. Ltd., Sumitomo Pharma Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the chronic obstructive pulmonary disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report: https://www.reportlinker.com/p04016579/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001